In our previous study, water-soluble extracts from Bursaphelenchus xylophilus (B. xylophilus), a pine wood nematode, were shown to enhance interleukin (IL)-4 plus lipopolysaccharide-induced polyclonal immunoglobulin (Ig) E production in vitro in mice and to increase serum levels of an antigen-nonspecific IgE in vivo. Here we examined whether the nematode extracts stimulate immunofunctions of murine peritoneal macrophages. In both resident and inflammatory macrophages, Fc receptor-mediated phagocytosis was markedly activated by B. xylophilus extracts, while non-specific phagocytosis was not. The enhancement of specific phagocytosis was accompanied by an increase in the formation of IgG-Fc receptor rosettes. B. xylophilus extracts also stimulated IL-1 production in both types of macrophages, and enhanced NO production and mRNA expression of inflammatory cytokines in inflammatory macrophages. These results indicate that the extracts of B. xylophilus contain an activating substance(s) for immunofunctions in macrophages, besides an enhancing factor for polyclonal IgE production.
It is well-known that infection with animal parasitic nematodes or administration of extracts of them can cause intense antigen-specific and nonspecific polyclonal immunoglobulin E (IgE) production, [1] [2] [3] which is dependent on interleukin (IL)-4 production linked with the development of the Th2 response. [4] [5] [6] The increase in parasitic antigen-specific IgE is associated with elimination of parasites from infected hosts, 7) while the increase in antigen-nonspecific polyclonal IgE can be involved in the survival of invading parasites. 2, 4, 8) Recently, Lynch et al. have reported a parallel relationship between the decline of parasitosis and increase in allergic disease. 9, 10) These findings suggest that the allergen-specific IgE produced is diluted by abundant nonspecific polyclonal IgE and that the resulting polyclonal IgE accumulation might be responsible for inhibiting allergy reaction with a saturation of Fc" receptors on mast cells.
In our previous study, we found that extracts of an animal non-parasitic nematode, as well as animal parasitic nematodes, show polyclonal IgE-inducing activities.
11) The animal non-parasitic nematode is a pine wood nematode, Bursaphelenchus xylophilus (B. xylophilus), transmitted by the pine sawyer, Monochamus alternatus. It is considered that this plant parasite causes pine wilt disease. 12) B. xylophilus extracts not only augmented IL-4 plus lipopolysaccharide (LPS)-induced polyclonal IgE production in murine splenocytes in vitro, but also increased the serum level of polyclonal IgE in immunized mice. 11) These results indicate that B. xylophilus extracts contain an enhancing substance(s) for polyclonal IgE production by humoral immunity. But, whether the extracts activate cellmediated immunity is not yet clear.
Macrophages are one of the immunocompetent cells and are associated with both cell-mediated and humoral immunity. They play a role in tumor killing, protection of microbial infections, and antigen presenting. 13, 14) In addition, the importance of macrophage activation in host immune responses against nematode infection has been documented. For example, mononuclear phagocytes increase or are activated during infection by nematodes, 15, 16) macrophages kill infective larvae of Nippostrongylus brasiliensis in vitro in the presence of complement and enhance IgG-dependent eosinophilmediated killing of nematodes, 17) and nitric oxide (NO) production by macrophages is useful for parasite killing. 18) On the other hand, a secreted product of the filarial nematode Acanthocheilonema viteae suppresses production of IL-6, IL-12, and tumor necrosis factor (TNF)-from murine macrophages activated by interferon (IFN)-þ LPS. 19) In this study, we examined whether B. xylophilus extracts promote macrophage functions such as Fc y To whom correspondence should be addressed. Fax: +81-86-251-7960; E-mail: iyamamoto@pheasant.pharm.okayama-u.ac.jp receptor-mediated phagocytosis and IL-1 production in both resident and inflammatory macrophages. We also investigated whether the nematode extracts enhance NO production and mRNA expression of inflammatory cytokines such as IL-1, IL-6, TNF-, and granulocyte-macrophage colony-stimulating factor (GM-CSF) in inflammatory macrophages.
Materials and Methods
Animals. Female BALB/c mice, 7 weeks old, were purchased from Charles River Japan (Yokohama, Japan). The care and use of the animals in this study followed the guidelines of Okayama University. Mice were kept in our animal facility for 1 week before use. All mice were used at 8 to 12 weeks of age. They were housed in a room controlled as to temperature (23) (24) (25) C), humidity (50-60%), and a preset light-dark cycle (12 h:12 h), bred with sterile wood-chip bedding, and provided with food and water ad libitum under specific pathogen-free conditions.
Reagents. RPMI-1640 medium was purchased from ICN Biomedicals Japan (Tokyo). Eagle's MEM was from Nissui Pharmaceutical (Tokyo). FBS was from Gibco BRL (Gaithersburg, MD). Thioglycollate medium was from Difco Laboratories (Detroit, MI). Heparin sodium salt was from Wako Pure Chemical Industries (Osaka, Japan). Penicillin G potassium was from Banyu Pharmaceutical (Tokyo). Streptomycin sulfate was from Meiji Seika (Tokyo). HRP-conjugated streptavidin was from Zymed Laboratories (San Francisco, CA). 3,3 0 ,5,5 0 -Tetramethylbenzidine (TMB), Escherichia coli LPS, and bovine serum albumin (BSA) (Fraction V) were purchased from Sigma Aldrich Japan (Tokyo). Sulfanilamide and N-1-naphthylethylenediamine dihydrochloride were from Nacalai Tesque (Kyoto, Japan). Sheep red blood cell (SRBC) was from Japan Ram (Hiroshima, Japan). Rabbit anti-SRBC IgG fraction was from Inter-cell Technologies (Hopewell, NJ). Rat antimouse IL-1, biotinylated goat anti-mouse IL-1, and recombinant mouse IL-1 were from R&D Systems (Minneapolis, MN). Giemsa's solution was from Merck Japan (Tokyo). RNAzol B was from Tel Test (Friendswood, TX). M-MLV reverse transcriptase and RNase inhibitor were from Toyobo (Osaka, Japan). Oligo (dT) 12{18 primer was from Life Technologies (Rockville, MD). The Quantitative PCR Detection Kit was from BioSource International (Camarillo, CA). Ex Taq and RNase were from Takara Bio (Otsu, Japan).
Preparation of Bursaphelenchus xylophilus extract. Bursaphelenchus xylophilus (B. xylophilus) and Botrytis cinerea (B. cinerea) were kindly provided by K. Kawazu, Emeritus Professor of Okayama University. The culture of B. xylophilus was as described previously. 12) Briefly, B. cinerea, whose mycelia were ingested by B. xylophilus, was cultured on a Czapek-Dox modification agar plate (0.2% NaNO 3 , 0.1% K 2 HPO 4 , 0.005% KCl, 0.005% MgSO 4 , 0.0001% FeSO 4 , 3.6% glucose, and 1.5% agar) in a plastic dish ( 100 mm) for 1 week at 26 C. B. xylophilus was added to the plate and cultured for 5-7 d at 26 C in the dark. After cultivation, the propagated nematodes were collected from the agar plates in a clean bench for 12 h by the Baermann funnel method. The collected nematodes were washed five times with sterile water, homogenized with an ultrasonic generator, and centrifuged twice at 10;500 Â g for 20 min. The supernatant was lyophilized and store at 4 C until use. The content of protein in the extracts comprised about 28% of the total weight. The extracts were analyzed for the presence of LPS by the Limulus amebocyte lysate test (BioWhittaker, Walkersville, MD), and were found to contain 3.1 ng of LPS/mg of the extracts.
Ingestion and rosette formation assays. The mice were intraperitoneally injected with 2.0 ml of 3% (w/v) thioglycollate medium. Exudate cells were harvested by peritoneal lavage with 7.5 ml phosphate-buffered saline (PBS) containing 20 U/ml heparin sodium salt 4 d after injection. After washing, the cells were resuspended in RPMI-1640 medium containing 100 U/ml penicillin G potassium and 0.1 mg/ml streptomycin sulfate and enumerated. The desired number (1{2 Â 10 6 cells/ml) of peritoneal exudate cells was determined. Aliquots of the cells (0.5 ml) were layered onto 15-mm cover glass (Matsunami Glass, Osaka, Japan) which had been placed in the 16-mm diameter wells of tissue culture plates (Nalge Nunc International, Rochester, NY) and incubated at 37 C in a 5% CO 2 incubator for 1 h to allow thioglycollate-elicited macrophage adherence to the cover glasses. Resident macrophages were obtained from untreated mice in a similar manner to that described above. Nonadherent cells were removed, 0.5 ml of RPMI-1640 containing various concentrations of reagents was added, and the cells were cultured for 3 h. Ingestion of SRBC coated with immunoglobulin G (SRBC-IgG) was determined according to Yamamoto et al. 20) Briefly, washed erythrocytes were coated with subagglutinating dilutions of purified rabbit anti-SRBC IgG fraction for 15 min at 37 C. For Fc receptormediated ingestion assay, 0.5 ml of 0.5% suspension of the SRBC-IgG in RPMI-1640 medium without FBS was overlayed on each macrophage-coated (monolayer) cover glass and cultured at 37 C in a humidified 5% CO 2 incubator for 90 min. Noninternalized erythrocytes were lysed by immersing the cover glass in a hypotonic solution (1:5 PBS) for 5-10 s. In the case of rosette formation, the macrophage monolayer and SRBC-IgG were cultured at 4 C for 60 min. Nonbinding erythrocytes were washed five times with PBS. The macrophages were fixed and stained with Giemsa's solution. Ingestion and rosetting formation were quantified microscopically. The data were expressed as ingestion and rosetting indexes according to Bianco et al. 21) and Fadok et al. 22) respectively. Ingestion (rosetting) index = % macrophages with ingested (rosetted) erythrocytes x average number of erythrocytes ingested (rosetted) per macrophage.
Determination of IL-1 level. Peritoneal cells (1 Â 10
5 cells) were added to 96-well flat-bottom tissue culture plates (Nunc, Roskilde, Denmark) and incubated at 37 C in a 5% CO 2 incubator for 1 h to allow macrophage adherence. Nonadherent cells were removed, and then cultured for 24, 48, and 72 h in RPMI-1640 medium containing 10% FBS with various reagents. Supernatants were collected and the IL-1 level was quantified by sandwich ELISA. 23 ) ELISA plates (Maxisoap, Nunc) were coated with 50 ml of antimouse IL-1 (4 mg/ml) overnight at 4 C. After washing and blocking (1% BSA in 7.5 mM PBS), the wells were seeded with 50 ml of culture medium and incubated for 2 h at room temperature. After washing, 50 ml of biotinconjugated anti-mouse IL-1 (100 ng/ml) was added. After 2 h, the IL-1 level was determined using HRPconjugated streptavidin, a substrate solution that consisted of 0.1 mg TMB per ml in 0.1 M acetate buffer (pH 5.5), and 0.004% H 2 O 2 . After a stop solution (2 N H 2 SO 4 ) was added, the plates were read at a wavelength of 450 nm with an ELISA reader (Model 680 Microplate Reader, BIO-RAD, Hercules, CA).
Measurement of NO production. NO release was quantified by the accumulation of nitrite in the supernatants of peritoneal macrophage cultures, using the standard Griess method. 24) Briefly, peritoneal cells (2 Â 10 5 cells) were added to 96-well flat-bottom tissue culture plates (Nunc), and the plates were incubated at 37 C in a 5% CO 2 incubator for 1 h to allow macrophage adherence. Nonadherent cells were removed and 0.2 ml of RPMI-1640 containing various concentrations of reagents was added. After 24 h, 100 ml of the supernatant was harvested and added to the same volume of Griess reagent (1% sulfanilamide, 0.1% N-1-naphthylethylenediamine dihydrochloride, and 2.5% H 2 SO 4 ) freshly prepared prior to use. Standards were prepared using sodium nitrite solutions (3.125-100 mM), and added to each assay plate. The plates were read at 550 nm with an ELISA reader.
Determination of inflammatory cytokine mRNA levels. Peritoneal macrophages (1 Â 10 7 cells) were cultured with 300 mg/ml of B. xylophilus extract or 10 mg/ml of LPS in 100-mm diameter tissue culture dishes (BD Biosciences, Franklin Lakes, NJ). After 3 h, the cells were harvested and washed twice by MEM. The total cellular RNA was isolated using the RNAzol B reagent, and then reverse-transcripted using M-MLV reverse transcriptase and oligo (dT) 12{18 primer. Briefly, 0.5 mg oligo (dT) 12{18 primer and 10 mg RNA were mixed and incubated at 72 C for 15 min. The resulting mixture was added to 50 mM Tris-HCl, 75 mM KCl, 3 mM MgCl 2 , 10 mM DTT, 40 units RNase inhibitor, 5 mM dNTP, and 200 units reverse transcriptase, and the mixture incubated at 42
C for 1 h. The reaction mixture was then heated at 70 C for 15 min and treated with RNase H at 37 C for 30 min. The mRNA levels of macrophage inflammatory cytokines (IL-1, IL-6, TNF-, TGF-, and GM-CSF) were determined with a Quantitative PCR Detection Kit. Aliquots of cDNA synthesized as above were used as a template for polymerase chain reaction (PCR). The PCR reaction mixture consisted of 0.25 mM dNTP, the primer mixture, a cDNA sample, and 0.25 U Ex Taq. The conditions for PCR were 94 C (denatura-
Results

Effect of B. xylophilus extracts on Fc receptormediated phagocytosis and rosette formation in peritoneal macrophages
Phagocytosis by macrophages is one of the most important roles in the immune system when foreign bodies invade. Especially, antigen-antibody (IgG) complex can easily be treated through the Fc receptor for IgG (the Fc receptor) on the macrophage membrane. 25) We examined whether B. xylophilus extracts promote Fc receptor-mediated phagocytosis in peritoneal macrophages elicited by thioglycollate medium. As shown Fig. 1A , Fc receptor-mediated phagocytosis was increased by B. xylophilus extracts at concentrations from 50 mg/ml to 1,000 mg/ml. A maximal response was obtained at a concentration of 300 mg/ml. In addition, LPS did not affect Fc receptor-mediated phagocytosis in thioglycollate-elicited macrophages (data not shown). The effect of B. xylophilus extracts on rosette formation was also investigated (Fig. 1B) . Rosette formation in which Fc receptor combines with antigen-IgG complex is the first step in phagocytosis. Rosette formation was increased by B. xylophilus extracts at concentrations from 10 mg/ml to 1,000 mg/ ml. A maximal response was obtained at a concentration of 100 mg/ml. The profile of rosette formation enhanced by the extracts agreed fairly well with that of phagocytosis, although a slight difference in the optimum concentration was observed between the two experiments.
In a similar manner to that above, we examined whether B. xylophilus extracts activate resident macrophages. Fc receptor-mediated phagocytosis was increased by the extracts at concentrations from 0.1 mg/ml to 1 mg/ml (Fig. 1C) . At concentrations of 100 mg/ml or greater, phagocytosis was suppressed as compared with the control. Rosette formation also increased at concentrations from 0.01 mg/ml to 0.1 mg/ml (Fig. 1D) . In resident macrophages, as well as thioglycollate-elicited macrophages, there was agreement in the profiles of phagocytosis and rosette formation enhanced by the extracts. On the other hand, B. xylophilus extracts did not affect non-specific phagocytosis by resident and thioglycollate-elicited macrophages (data not shown).
Effect of B. xylophilus extracts on IL-1 production in peritoneal macrophages
IL-1, one of various cytokines produced by macrophages, is the essential cytokine triggering primary immune responses. 26) Hence, we examined whether B. xylophilus extracts modulate IL-1 production in resident and thioglycollate-elicited macrophages. The levels of IL-1 were estimated by ELISA after 24 h incubation. B. xylophilus extracts enhanced IL-1 production in the thioglycollate-elicited macrophages at concentrations ranging from 1 mg/ml to 1,000 mg/ml ( Fig. 2A) . In the resident macrophages, the extracts also increased IL-1 secretion at concentrations ranging from 1 mg/ml to 100 mg/ml (Fig. 2B) . The IL-1 production of the resident macrophages was higher than that of the thioglycollate-elicited macrophages by the addition of the extracts at concentrations of 1-100 mg/ml. Moreover, the enhancement of IL-1 production was maintained until 72 h in both macrophages (data not shown). These findings suggest that B. xylophilus extracts can contribute to the enhancement of the cell-mediated immune response after phagocytosis of foreign bodies.
Effect of B. xylophilus extracts on nitrite production in peritoneal macrophages elicited by thioglycollate medium
Nitric oxide (NO), which is released mainly by activated macrophages, is well-known as an effector molecule for killing infectious and tumor cells. 27) Furthermore, it is well-known that IL-1 leads the enhancement of NO production. 28) Hence, we measured the amount of NO production in peritoneal macrophages elicited by thioglycollate medium (Fig. 3A) . NO production was dose-dependently enhanced by the extracts, reaching a maximal level at concentrations of 100 mg/ml or greater. Additionally, NO production was also investigated in thioglycollate-elicited macrophages cultured with LPS and B. xylophilus extracts (Fig. 3B) . A suboptimal concentration (500 ng/ml) of LPS was employed for evaluation of an additive or synergistic effect with B. xylophilus extracts. The extracts did not effect NO production by LPS.
Effect of B. xylophilus extracts on mRNA expression of inflammatory cytokines in peritoneal macrophages elicited by thioglycollate medium
We investigated whether B. xylophilus extracts induce mRNA expression of various cytokines in the thioglycollate-elicited macrophages, because the foregoing results make it clear that the extracts activate macrophage functions. The mRNA expression of IL-1, IL-6, TNF-, and GM-CSF as inflammatory cytokines and TGF-was analyzed by a RT-PCR technique after 3 h incubation with 300 mg/ml of B. xylophilus extract. Each induction level was compared with that of LPS (10 mg/ml). As shown Fig. 4 , the IL-1 mRNA level was increased by the extracts. This result agrees well with the enhancement of the IL-1 protein level (Fig. 2A) . The IL-6, TNF-, and GM-CSF mRNA levels were also increased by B. xylophilus extracts. In particular, the mRNA expression of IL-6 was markedly enhanced. TGF-, a cytokine that suppress the inflammatory response, was not induced by the extracts. LPS showed the same induction profile in the mRNA expression of inflammatory cytokines as did B. xylophilus extracts. These results indicate that B. xylophilus extracts activate macrophage function extensively and contribute to immunopotentiation.
Discussion
In a previous paper, we reported that B. xylophilus extracts augmented the polyclonal IgE production induced by LPS and IL-4 in murine splenocytes and purified B cells as determined by ELISA and ELIspot assays. 11) We also observed that the antigen-nonspecific IgE levels were increased in the sera of mice treated Murine peritoneal macrophages (1 Â 10 5 cells) were cultured with various doses of B. xylophilus extracts for 24 h at 37 C in 96-well culture plates. After incubation, conditioned media were harvested and IL-1 levels were determined by ELISA. Values are means AE S.D. for triplicate cultures. Statistical significance was determined by Student's t test.
Ã , P < 0:05; ÃÃ , P < 0:01; ÃÃÃ , P < 0:001, as compared with values of their respective controls. N.D., not detectable. with the extracts. Additionally, our preliminary data indicated that B. xylophilus extracts stimulate Th1 type cytokines such as IFN-(data not shown). This evidence implies that the extracts include various immunomodulating substances. Our attention is focused on the effect of B. xylophilus extracts on macrophage functions, because macrophages are well-known as effector cells against nematodes. [15] [16] [17] [18] In this study, we found that B. xylophilus extracts enhanced Fc receptor-mediated phagocytosis in both thioglycollate-elicited and resident macrophages. The extracts also induced NO production and mRNA expression of inflammatory cytokines such as IL-1, IL-6, TNF-, and GM-CSF in thioglycollateelicited macrophages.
Macrophages have various functions, such as elimination of foreign bodies and body wastes, tumor cell cytotoxicity, antigen presenting, and T-cell activation with monokine production. 13, 14) Macrophages are derived from monocytes which are differentiated from myeloid stem cells and stationed in tissues. These cells are named resident macrophages and act mainly in elimination of foreign bodies and body wastes. When resident macrophages are stimulated by IFN-or LPS, they become activated macrophages and accelerate their function markedly. On the other hand, thioglycollateelicited macrophages are pre-activated macrophages that have migrated to the peritoneal by thioglycollate broth. These macrophages are named inflammatory macrophages, and are additionally activated by IFN-or LPS, like as same as resident macrophages. They remove invading foreign bodies by phagocytosis. Phagocytosis falls into two types, non-specific and specific. Specific phagocytosis includes Fc receptor-mediated phagocytosis, known as the IgG-dependent pathway, Fc" receptor-mediated phagocytosis, known as the IgEdependent pathway, and C3 receptor-mediated phagocytosis, known as the complement 3-dependent pathway. These pathways play a major role in eliminating germs and so on effectively. 29) B. xylophilus extracts enhanced Fc receptor-mediated phagocytosis in both resident and inflammatory macrophages (Fig. 1A and C) . The enhancement of Fc receptor-mediated phagocytosis by B. xylophilus extracts was accompanied by an increase in rosette formation (Fig. 1B and D) . Fc receptor-mediated phagocytosis consists of two steps in the mechanism. In the first step, antigen-antibody complex binds to the Fc receptor on the macrophage membrane (rosette formation). In the second step, antigen-antibody-receptor complex is incorporated by endocytosis (phagocytosis). Therefore, these results suggest that B. xylophilus extracts induce augmentation of the number of Fc receptors on the macrophage membrane and enhance Fc receptor-mediated phagocytosis. In addition, it is interesting that the resident macrophages activated the Fc receptor-mediated phagocytosis at lower concentrations of B. xylophilus extracts than inflammatory macrophages did. The optimal concentrations in resident and inflammatory macrophages were 1 mg/ml and 300 mg/ml respectively ( Fig. 1A and C) . The resident macrophages also enhanced IL-1 production at lower concentrations of the extracts than inflammatory macrophages did (Fig. 2) . It has been reported that galactose/ N-acetylgalactosamine specific lectin was expressed on the membrane of inflammatory macrophages but not of resident macrophages. 30, 31) It is also known that the number of receptors changes according to the macrophage-activating state. The C5 component, which is produced from the inflammatory macrophages, upregulates the number of complement receptors and Fc receptors. 32, 33) The lectins or receptors on the macrophage membrane lead to activation of macrophages per se. These reports indicate that a characteristic of macrophages is dependent on the macrophage-activating state. Therefore, our different results between resident and inflammatory macrophages might be caused by the expression change of the number and variety of receptors.
NO production is one of the roles of inflammatory macrophages. NO is a major effector molecule of macrophage cytotoxicity against a variety of microbial targets, including protozoan and helminth parasites. Hibbs et al. reported that macrophage cytotoxicity for tumor or infected cells is L-arginine dependent and that the active molecule of this new pathway is NO. 34, 35) As shown in Fig. 3 , NO production from inflammatory macrophages was markedly increased by B. xylophilus extracts dose-dependently. It is known that IL-1 has the were cultured with B. xylophilus extract (300 mg/ ml) or LPS (10 mg/ml) for 3 h at 37 C in a plastic dish ( 100-mm). After mRNA extraction, mRNA was examined by RT-PCR using a Quantitative PCR detection kit. The PCR samples were subjected to agarose gel electrophoresis and stained by EtBr. , control; , B. xylophilus extract; , LPS. The level of mRNA expression was analyzed using a densitometer. The data are expressed as values relative to the control culture. function of inducible NO synthetase (iNOS) inducer of thioglycollate-elicited macrophages, and that TNFaugments NO-dependent macrophage cytotoxicity against Entamoeba histolytica.
27,36) B. xylophilus extracts induced production of IL-1 and mRNA expression of IL-1 and TNF-in thioglycollate-elicited macrophages ( Figs. 2A and 4) . Thus it seems that B. xylophilus extracts directly induced NO production and that the extracts increased IL-1 and/or TNFlevels, and then induced NO production indirectly. Furthermore, we observed that mRNA expression of GM-CSF and IL-6, as well as of IL-1 and TNF-, was increased by the addition of B. xylophilus extracts (Fig. 4) . The expression of TGF-, known as a suppressive factor of macrophages, had no influence. These results are similar to the response of macrophages that are stimulated by LPS, but LPS did not enhance Fc receptor-mediated phagocytosis (data not shown), and B. xylophilus extracts did not affect the NO production induced by LPS at a suboptimal concentration (Fig. 3B) . Therefore, it is not thought that LPS acts as a macrophage-activating factor in B. xylophilus extracts. We also examined the activities of Botrytis cinerea (a bait for B. xylophilus), Ascaris suum (an animal-parasitic nematode), and Caenohabditis elegans (a non-parasitic soil nematode) extracts. These extracts had no influence or little activation on macrophage function (data not shown), indicating that not all nematode extracts can activate macrophage functions. Moreover, we tested the effect of B. xylophilus extracts treated at 100 C for 10 min on Fc receptor-mediated phagocytosis in macrophages. The activation of macrophages was not affected by the heat treatment, although polyclonal IgE induction was abrogated (data not shown). These results suggest that B. xylophilus extracts include a macrophage-activating substance(s) other than LPS and a polyclonal IgE-inducing factor(s), and that the extracts might serve as an immunomodulator through macrophage activation against cancer or infectious disease.
In recent years, type I allergic diseases such as atopic dermatitis, bronchial asthma, and pollinosis have been increasing with the expulsion of parasites, especially in modern countries. 37) An allergy-suppressive effect of parasite extracts by enhancing polyclonal IgE production has also been reported. 38) Additionally, we showed that B. xylophilus extracts induced polyclonal IgE in our previous report.
11 ) These facts suggest that B. xylophilus extracts have an allergy-suppressive effect. But, since certain parasite extracts enhance the Th2-type response markedly, 39) parasite extracts appear to show suppression of the Th1-type response and the consequent high risk of infectious disease or cancer. In this study, B. xylophilus extracts promoted Fc receptor-mediated phagocytosis and inflammatory cytokine production. These results suggest that B. xylophilus extracts can suppress the allergic reaction by polyclonal IgE induction without inhibition of the Th1 response. These data on the immunobiological features of B. xylophilus extracts should facilitate the development of vaccination therapy for allergy. Further studies are in progress to identify the components of B. xylophilus extracts for macrophage activation as well as polyclonal IgE production, and to determine the mechanism of action of these compounds.
